Trademark Alertz ®
Search
Trademark
Owner
Trademark: CRINETICS 2385432
Word
CRINETICS
ID
2385432
Trademark Type
Word
Status
Registered: Registered/protected
Application Date
01 September 2023
Registration Date
01 September 2023
Renewal Date
01 September 2033
Owner(s)
Crinetics Pharmaceuticals, Inc.
Service
Spruson & Ferguson
Goods and Services:
Class 5
:
Pharmaceutical preparations for modulating neuropeptides and G-protein coupled receptors (GPCRs)
;
pharmaceutical preparations for use in oncology
;
pharmaceutical preparations for use in treating endocrine disorders and endocrine related diseases
;
pharmaceutical preparations targeting neuropeptide receptors
;
pharmaceutical preparations for the treatment of cancer, acromegaly, neuroendocrine tumors, Cushing’s Disease, hyperinsulinism, carcinoid syndrome, congenital adrenal hyperplasia, hypercalcemia, chronic pain, hyperparathyroidism, polycystic kidney disease, Grave’s disease, thyroid eye disease, thyroid ophthalmopathy, diabetes, obesity, insulinoma, hypoglycemia, androgen deficiency, infertility, thyroid cancer, growth hormone deficiency, hypoparathyroidism, nonfunctional pituitary adenomas, polycystic liver disease, and type two diabetes
;
therapeutic preparations for the treatment of ocular diseases and disorders, metabolic diseases and disorders, hormonal diseases and disorders, reproductive diseases and disorders, bone diseases and disorders, digestive diseases and disorders, gastroenterological diseases and disorders, and thyroid diseases and disorders.
Class 42
:
Medical research services
;
scientific research and development
;
pharmaceutical research and development
;
therapeutic research and development
;
research and development in the field of oncology
;
medical research for treating cancer, endocrine disorders, acromegaly, neuroendocrine tumors, Cushing’s Disease, hyperinsulinism, chronic pain, hypercalcemia, hyperparathyroidism, polycystic kidney disease, Grave’s disease, thyroid eye disease, thyroid ophthalmopathy, diabetes, obesity, insulinoma, hypoglycemia, androgen deficiency, infertility, thyroid cancer, growth hormone deficiency, hypoparathyroidism, nonfunctional pituitary adenomas, polycystic liver disease, and type two diabetes
;
pharmaceutical research for treating cancer, endocrine disorders, acromegaly, neuroendocrine tumors, Cushing’s Disease, hyperinsulinism, and chronic pain, hypercalcemia, hyperparathyroidism, polycystic kidney disease, Grave’s disease, thyroid eye disease, thyroid ophthalmopathy, diabetes, obesity, insulinoma, hypoglycemia, androgen deficiency, infertility, thyroid cancer, growth hormone deficiency, hypoparathyroidism, nonfunctional pituitary adenomas, polycystic liver disease, and type two diabetes
;
therapeutic research for ocular diseases and disorders, metabolic diseases and disorders, hormonal diseases and disorders, reproductive diseases and disorders, bone diseases and disorders, digestive diseases and disorders, gastroenterological diseases and disorders, and thyroid diseases and disorders
;
providing medical and scientific research information in the fields of pharmaceuticals and therapeutics.